Salta al contenuto
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avanzata
  • Acarbose was effective in main...
  • Citazione
  • Invia SMS
  • Invia email
  • Stampa
  • Esporta il record
    • Esporta a RefWorks
    • Esporta a EndNoteWeb
    • Esporta a EndNote
  • PLink permanente
Acarbose was effective in maintaining glycemic control in type 2 diabetes mellitus but was associated with adverse effects

Acarbose was effective in maintaining glycemic control in type 2 diabetes mellitus but was associated with adverse effects

Dettagli Bibliografici
Autori principali: Holman, R, Dinneen, S
Natura: Journal article
Lingua:English
Pubblicazione: 1999
  • Posseduto
  • Descrizione
  • Documenti analoghi
  • MARC21

Documenti analoghi

  • The effect of combination therapy of sulfonylurea, metformin, and acarbose in type 2 diabetes mellitus patients
    di: Tri Murti Andayani,, et al.
    Pubblicazione: (2009-12-01)
  • A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)
    di: Holman, R, et al.
    Pubblicazione: (1999)
  • Effects of the addition of acarbose to insulin and non-insulin regimens in veterans with type 2 diabetes mellitus
    di: Wettergreen SA, et al.
    Pubblicazione: (2016-12-01)
  • Improved glycemic control by acarbose therapy in hypertensive diabetic patients: effects on blood pressure and hormonal parameters
    di: P. Rosenbaum, et al.
    Pubblicazione: (2002-08-01)
  • Impact of baseline characteristics on glycemic effects of add‐on saxagliptin or acarbose to metformin therapy: Subgroup analysis of the SMART study in Chinese patients with type 2 diabetes mellitus
    di: Hui Fang, et al.
    Pubblicazione: (2020-07-01)

Opzioni di ricerca

  • Ultime ricerche
  • Ricerca avanzata

Cerca

  • Scorri il catalogo
  • Scorri in ordine alfabetico
  • Esplora selezioni
  • Materiali riservati (per i corsi)
  • Nuovi documenti

Serve aiuto?

  • Suggerimenti per la ricerca
  • Chiedi al bibliotecario
  • FAQ